Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis

Published:2022-11 Issue: Volume:124 Page:S90-S103
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Nasiri Mohammad Javad,Zangiabadian Moein,Arabpour Erfan^ORCID,Amini Sirus,Khalili Farima,Centis Rosella^ORCID,D'Ambrosio Lia^ORCID,Denholm Justin T.^ORCID,Schaaf H. Simon^ORCID,van den Boom Martin,Kurhasani Xhevat,Dalcolmo Margareth Pretti^ORCID,Al-Abri Seif^ORCID,Chakaya Jeremiah^ORCID,Alffenaar Jan-Willem^ORCID,Akkerman Onno,Silva Denise Rossato^ORCID,Muňoz-Torrico Marcela,Seaworth Barbara^ORCID,Pontali Emanuele^ORCID,Saderi Laura,Tiberi Simon^ORCID,Zumla Alimuddin^ORCID,Migliori Giovanni Battista^ORCID,Sotgiu Giovanni

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference62 articles.

1. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis;Ahmad;Lancet,2018

2. Effectiveness and cardiovascular safety of delamanid-containing regimens in adults with multidrug-resistant or extensively drug-resistant tuberculosis: A nationwide cohort study from Belarus, 2016-18;Auchynka;Monaldi Arch Chest Dis,2021

3. Operating characteristics of a rank correlation test for publication bias;Begg;Biometrics,1994

4. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study;Borisov;Eur Respir J,2017

5. Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report;Borisov;Eur Respir J,2019

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of effectiveness and safety of delamanid-containing regimens using individual patient datasets;The International Journal of Tuberculosis and Lung Disease;2024-09-01

2. Candidate anti-tuberculosis medicines and regimens under clinical evaluation;Clinical Microbiology and Infection;2024-09

3. Delamanid and bedaquiline resistance patterns in Mycobacterium tuberculosis in Iran: A cross-sectional analysis;New Microbes and New Infections;2024-08

4. A Narrative Review of Bedaquiline and Delamanid: New Arsenals Against Multidrug‐Resistant and Extensively Drug‐Resistant Mycobacterium tuberculosis;Journal of Clinical Laboratory Analysis;2024-08

5. Clinical outcomes of multidrug-resistant tracheobronchial tuberculosis receiving anti-tuberculosis regimens containing bedaquiline or delamanid;Scientific Reports;2024-07-29